Results 211 to 220 of about 2,325,434 (292)

Deficiency of mineralocorticoid receptor signalling in myeloid cells protects cardiac and kidney function in hypertensive diabetic mice. [PDF]

Clin Sci (Lond)
Tesch GH, Ozols E, Morgan J, Young MJ, Nikolic-Paterson DJ.   +4 more
europepmc   +1 more source

Mineralocorticoid receptor blockade for renoprotection

Kidney Research and Clinical Practice, 2018
openaire   +3 more sources

Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetes. [PDF]

BMJ Open
Bitsch Poulsen M, Okdahl T, Buciek JH, Drewes AM, Karlsson P, Ahluwalia TS, Brock B, Brock C, Rossing P, Hansen CS.   +9 more
europepmc   +1 more source

Double 'A' phenotypes with mineralocorticoid deficiency: A rare presentation of Allgrove syndrome. [PDF]

Clin Pediatr Endocrinol
Ghosh A, Annigeri S, Singh C, Hemram SK.
europepmc   +1 more source

Kidney Disease and Mineralocorticoid Receptor

Nihon Naika Gakkai Zasshi, 2009
openaire   +3 more sources

Lipopolysaccharide Sensitizes Steroid-Induced Brain Injury in Neonatal Rat Pups. [PDF]

Mediators Inflamm
Chang YS, Yang TM, Hsu YL, Kuo YM, Lin CH.   +4 more
europepmc   +1 more source

The Role of Aldosterone in Vascular Permeability in Diabetes. [PDF]

Cells
Aleksiejczuk M, Bielicka N, Bruzgo-Grzybko M, Kalita IS, Olichwier AJ, Mierzejewska P, Stelmaszewska J, Dzieciol J, Chabielska E, Gromotowicz-Poplawska A.   +9 more
europepmc   +1 more source

Rethinking Potassium Management in Chronic Kidney Disease-A Modern Approach. [PDF]

J Clin Med
Kog ZX, Lee IWZ, Teh SP.
europepmc   +1 more source

The Emerging Role of Aldosterone Synthase Inhibitors in Overcoming Renin-Angiotensin-Aldosterone System Therapy Limitations: A Narrative Review. [PDF]

Card Fail Rev
Patel SK, Teoh H, Saunthar A, Yau TM, Verma S.   +4 more
europepmc   +1 more source